Canomiks
Techstars '20Cambridge, US · Founded 2016 · 5 employees on LinkedIn · 2 known investors
Find your way into Canomiks
3,161 people in our graph share verified history with the Canomiks team — schools, employers, funds. One of them is your warm intro.
Canomiks is a life sciences company focused on developing treatments and research in diabetes, cardiovascular disease, and related areas, drawing on expertise in pharmacology, genomics, and bioinformatics.
Also known as Canomiks Inc
Founders & leadership
Canomiks was founded in 2016 by Leena Pradhan-Nabzdyk.

Board
Investors · 2
How we know: GROOVE CAPITAL's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Canomiks is a life sciences company applying genomics, bioinformatics and AI to the functional food and beverage, dietary supplement, and cosmeceutical/skincare industries. It positions itself as the first technology company to use a genomics and AI-based platform to innovate new formulations and to validate, test and certify the biological efficacy and safety of ingredients and finished formulations. The company describes its vision as "Make Food as Medicine a Reality" and its mission as bringing truth, transparency and trust to these industries.
Its offerings span the product life cycle: Product Validation, which analyzes proprietary formulations and ingredients for effects on human genes to identify new health indications, uncover mechanisms of action, support existing claims and design clinical trials; Bio-B2B ingredient testing and certification, which standardizes the biological effects of botanical ingredients using human cells, genomics and AI to address batch-to-batch variation, supplier and crop variability, extraction differences and adulteration; and GeneTune research services, a proprietary bioinformatics software-based service supporting customized formulations and management of chronic conditions. Customers may use the CanTRUST by Canomiks validation or certification seal on marketing materials and packaging. Canomiks also operates WhatToTrust, a consumer-facing science-based dietary supplement rating and evaluation platform launched in June 2025, and publishes the IllumiNatur Edge newsletter for the nutraceutical and natural products industry. The company is registered in SAM.gov and available for federal contracts, SBIR partnerships and research collaborations.
Founding story
Canomiks was founded by three Harvard professors and scientists with more than 50 years of combined experience in bioinformatics, genomics, medicine, clinical science and pharmacology. Dr. Leena Pradhan-Nabzdyk and Dr. Manoj Bhasin grew up in India, where herbal and botanical medicine has long been practiced, and after moving to the United States observed the growth of the "food as medicine" trend and a need for evidence-based product development and improved nutraceutical ingredient testing and validation. Together with Dr. Frank LoGerfo they launched Canomiks to apply their combined expertise in genomics, medicine and pharmacology to the natural products industry.
Business model
Canomiks sells R&D and preclinical testing, validation and certification services to businesses across the natural products value chain, including ingredient suppliers, finished product manufacturers, marketers and retailers, with certification seals (CanTRUST) licensed for use on client marketing materials and packaging. Technology development has been partly funded by National Science Foundation grants, and the company is also positioned for federal contracts and SBIR partnerships.
Service-based fees for product validation, Bio-B2B ingredient testing and certification, and GeneTune bioinformatics research services sold to companies in the supplement, functional food and beverage, and skincare sectors; non-dilutive grant funding supplements technology development.
Traction
Canomiks reports serving ingredient, functional food and beverage, and dietary supplement companies internationally, a partnership with Ocean Spray for cranberry product innovation, repeated NSF SBIR grant awards (2022 and 2024), Launch Minnesota innovation grants, and industry awards from NutraIngredients-USA in 2025 and 2026.
Latest developments
In June 2025 Canomiks launched WhatToTrust, a science-based consumer platform for evaluating and rating dietary supplements, and won a 2025 NutraIngredients-USA award (Nutrition Research Project) for Bio-B2B at a July 14 ceremony in Chicago. Company news listings also cite a 2026 NutraIngredients-USA Editors' Award for Industry Initiative of the Year for WhatToTrust.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Canomiks describes itself as the first technology company to apply genomics and AI to validate, test and certify botanical ingredient efficacy and safety, and characterizes Bio-B2B as the first end-to-end solution for evaluating efficacy, safety and batch-to-batch consistency of botanical ingredients. It has been recognized by NutraIngredients-USA awards in 2025 and 2026, the MN Cup Food, Ag & Beverage division (2021), the PepsiCo Greenhouse Accelerator (2021) and the Techstars Farm to Fork Accelerator (2020).
Canomiks emphasizes its proprietary intellectual property and a combination of multi-omics science, AI and customizable bioassays that it says makes Bio-B2B the only platform delivering functional and safety insights at scale, covering efficacy, adulterant detection and batch-to-batch consistency, with pharmaceutical- and academic-grade methodologies applied to botanicals and a certification seal for client products.
Technology
The company combines multi-omics science (genomics and functional genomics), bioinformatics, AI and high-throughput biological testing using human cells and customizable bioassays. The Bio-B2B platform validates biological efficacy, detects contaminants and adulterants via functional genomics, and supports traceability across ingredient batches and sources; GeneTune is a proprietary bioinformatics software solution used to design customized formulations. Canomiks states it applies methodologies typically used in pharmaceutical development and academic research.
Go-to-market
Canomiks reaches clients directly through its solutions offering and certification seals, and builds visibility through industry conference presentations (e.g., SupplySide West, American Society of Pharmacognosy annual meeting), trade press and podcasts, industry awards, accelerator programs, a newsletter, and a consumer-facing rating platform. It is registered in SAM.gov for federal contracting and research collaborations.
Ingredient suppliers, finished product manufacturers, CPG companies, marketers and retailers in the dietary supplement, functional food and beverage, cosmetics and skincare industries; the WhatToTrust platform additionally addresses consumers choosing dietary supplements.
Geography
The 2025 press release datelines the company in Rochester, Minnesota, and describes it as a Minnesota-based life sciences startup; it says its solutions have benefited companies around the world.
History
The company was selected for the Techstars Farm to Fork Accelerator in 2020 and the PepsiCo Greenhouse program in January 2021. In 2021 it won the Food, Ag & Beverage division of the MN Cup pitch competition and received a Launch Minnesota Innovation Grant. In 2022 it was awarded a National Science Foundation SBIR grant, announced a partnership with Ocean Spray, and was among startups receiving Launch Minnesota innovation grants. In June 2024 Canomiks announced nearly $1 million in NSF funding to advance its botanical testing platform, and in October 2024 introduced AI-powered genomic testing for botanical ingredients. In June 2025 it launched the consumer platform WhatToTrust and won a 2025 NutraIngredients-USA award for Bio-B2B; a further NutraIngredients-USA Editors' Award for the WhatToTrust platform is listed for 2026.
Risks & controversies
Canomiks notes that biological efficacy testing for botanicals is not required by the FDA, and its materials carry the standard disclaimer that its statements have not been evaluated by the Food and Drug Administration and that products are not intended to diagnose, treat, cure or prevent disease.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 14
launches, deals, and filingsReceived the "Nutrition Research Project" award at the July 14 ceremony in Chicago.
$1M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 7
primary sources listed
- Canomikscanomiks.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Canomiks do?
- Canomiks uses genomics, bioinformatics and AI to validate, test and certify botanical ingredients for supplements and foods.
- Who founded Canomiks?
- Canomiks was founded by Leena Pradhan-Nabzdyk in 2016.
- Who are Canomiks's investors?
- Canomiks's investors include GROOVE CAPITAL, Techstars.
- Where is Canomiks headquartered?
- Canomiks is headquartered in Cambridge, US.




